Single-chain variable fragment albumin fusions bind the neonatal Fc receptor (FcRn) in a species-dependent manner: implications for in vivo half-life evaluation of albumin fusion therapeutics
The next wave dual and triple agonists (GLP-1 + GIP + glucagon: tirzepatide, retatrutide, survodutide) are showing superior fat loss, better hepatic outcomes, and potentially preserved lean mass
For reference: GHK-Cu 50mg $45 NAD+ 500mg $96 If you decide to give them a try, do me a favour and use code Peptide10 for 10% off your order
Chuback explains: What trans fats actually are Why they became so common in processed foods How they affect the arteries and cardiovascular system Why food labels can sometimes be misleading What ingredients people should pay attention to How small daily choices impact long-term heart health This is why awareness matters
Ro (Ro Body) Discontinued compounded GLP-1 programs
The pitch usually pairs a huge potency number with the word "synaptogenesis," and lands somewhere near: *this is the closest thing to a real limitless pill.* The gap between that pitch and "rats did better in a water maze" is enormous
